DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
$86.99 $0.72 per serving
Product analysis
EPA-DHA Balance provides omega-3 fats with a useful connection to lower triglycerides and possible modest joint support. Its EPA contribution offers good value, while the exact oil forms remain unclear.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
EPA and DHA are identified, but their exact forms are not clearly disclosed. That leaves uncertainty about the oil preparation and how readily the body can use it.
Ingredient Transparency70
The EPA and DHA amounts and their composition are disclosed. Their exact forms are not, so active quantities are easier to compare than preparations.
Value For Money60
EPA offers good value at the full serving cost, while DHA is comparatively expensive for its amount. The buying case is stronger when EPA is your priority.
Customer Satisfaction93
Customer feedback is very positive across many thousands of ratings. The broad review base supports confidence in satisfaction, without proving heart or joint benefits.
Product Focus70
The clearest role concerns EPA and DHA support for blood-fat levels, especially triglycerides. Wider expectations for skin, immediate focus or metabolism are less dependable.
- Format
Softgel - Container
- 240 Softgel(s)
- Per serving
- $0.72
- Also available
EPA-DHA Balance$48.99- Customer rating
- 4.8 · 17,268 ratings
Goals
Impact
Highest effect
EPA (Eicosapentaenoic Acid) · 800 mg
The explicitly declared EPA and DHA are relevant to triglyceride and selected vascular measures, with EPA leading the saved contribution. Fish-oil carrier mass and duplicate DHA catalogue identity do not create additional active doses. These surrogate findings do not establish routine prevention of major cardiovascular events, and neither triglyceride-form wording nor oil mass establishes superior clinical benefit.
How this product is rated for Heart Health
Ingredient fit84
The relevant ingredients are relatively focused on heart-health aspects. The counted amounts receive partial recognition overall, without establishing a clinically effective prevention regimen.
Goal fit
The relevant ingredients are relatively focused on heart-health aspects.
Dose adequacy
The counted amounts receive partial recognition overall, without establishing a clinically effective prevention regimen.
Pathways60
Triglyceride metabolism is the strongest contributing pathway, based on explicitly declared fatty-acid amounts. Only one evaluated pathway meets the breadth threshold.
Depth
Triglyceride metabolism is the strongest contributing pathway, based on explicitly declared fatty-acid amounts.
Breadth
Only one evaluated pathway meets the breadth threshold.
Evidence100
EPA (Eicosapentaenoic Acid) leads the saved finding. The counted preparations receive recognition, without proving the same population, duration or clinical outcome.
Evidence strength
EPA (Eicosapentaenoic Acid) leads the saved evidence finding; clinical interpretation remains specific to the ingredient and outcome.
Studied preparation
The counted preparations receive recognition, without proving the same population, duration or clinical outcome.
Formulation logic100
Each counted ingredient works independently or has its required partner; no extra combined benefit is established. No configured conflict was matched.
Partner coverage
Each counted ingredient works independently or has its required partner; no extra combined benefit is established.
Conflicts
No configured ingredient conflict was matched.
Effective doses
All counted ingredients meet the amount inclusion criterion, which is distinct from a clinically proven prevention threshold.
Impact
Highest effect
Fish Oil · 2000 mg
EPA and DHA can lower triglycerides, which is the main cardiovascular role supported here. The separately declared active amounts receive recognition, but total oil weight is not an additional active dose. Trials used particular exposures and populations, so the recorded triglyceride contribution does not demonstrate prevention of cardiovascular events or improved heart rhythm.
How this product is rated for Cardiovascular Support
Ingredient fit81
The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
Relevant ingredients sit within a broader formula containing other actives, which limits its focus on this goal.
Dose adequacy
The disclosed amounts provide partial support; smaller or unresolved quantities limit the amount finding.
Pathways60
The strongest recorded coverage concerns triglyceride metabolism; this is a mechanism finding, not proof of fewer cardiovascular events.
Depth
The strongest recorded coverage concerns triglyceride metabolism; this is a mechanism finding, not proof of fewer cardiovascular events.
Breadth
One cardiovascular mechanism reaches the coverage threshold, with limited coverage of the others.
Evidence83
EPA declared active provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
EPA declared active provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.
Formulation logic100
The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Impact
High effect
Fish Oil · 2000 mg
EPA and DHA can influence inflammatory fatty-acid mediators, with supplied human analyses reporting lower inflammatory markers. Their separate declarations receive recognition here and are not pooled into a guessed combined fish-oil dose. The generic fish-oil active amount remains unresolved. These findings do not establish a routine clinical anti-inflammatory benefit from this serving.
How this product is rated for Inflammation
Ingredient fit65
The formula includes relevant nutrients alongside broader ingredients. Unresolved declarations and small amounts limit how closely some ingredients match the supplied comparisons.
Goal fit
The relevant ingredient declarations form a focused comparison for this goal, although clinical applicability remains limited.
Dose adequacy
Declared amounts only partly match the supplied comparisons; unresolved active quantities cannot establish adequacy.
Pathways40
EPA and DHA provide the strongest assigned route through inflammatory fatty-acid mediators.
Depth
EPA and DHA provide the strongest assigned route through inflammatory fatty-acid mediators.
Breadth
Only one assigned route reaches the supplied coverage criterion, leaving limited breadth.
Evidence70
EPA leads the saved evidence finding, with supplied human analyses reporting changes in inflammatory markers.
Evidence strength
EPA leads the saved evidence finding, with supplied human analyses reporting changes in inflammatory markers.
Studied preparation
The supplied comparison accepts the relevant preparations; this does not establish equivalence of every formulation or a matching daily regimen.
Formulation logic100
No listed conflict or missing required partner is identified. Amount comparisons do not demonstrate an added benefit from combining ingredients.
Partner coverage
No required partner is missing among the recognized ingredients; this does not establish synergy.
Conflicts
No listed conflict is triggered by the supplied ingredient and amount facts.
Effective doses
All recognized ingredients meet the minimum amount comparison, which is not a proven biological threshold.
Impact
High effect
Omega-3 · 1200 mg
Omega-3 supplies fatty acids, but the generic identity does not establish routine skin improvement. Specific purified-EPA UV-challenge findings cannot be transferred to this fish-oil formulation. The fish-oil material amount is not an additional omega-3 dose.
How this product is rated for Skin Health
Ingredient fit92
Omega-3 provides the recognized skin connections. The declared counted amounts receive full recognition.
Goal fit
The recognized ingredients provide a focused skin connection, with links to other goals also affecting focus.
Dose adequacy
The counted amounts receive full recognition; this does not establish greater cosmetic benefit from larger supplement amounts.
Pathways50
The strongest recognized coverage concerns epidermal barrier lipids. Coverage is concentrated in one area.
Depth
Epidermal barrier lipids is the strongest recognized area; the supplied ingredient limitations still constrain practical expectations.
Breadth
One area meets the supplied coverage requirement, leaving limited breadth across other skin outcomes.
Evidence78
Omega-3 leads the saved evidence finding. Preparation, population and outcome limitations constrain transfer to routine skin benefits.
Evidence strength
Omega-3 has the strongest recognized evidence among the counted ingredients; its specific limitations determine which skin benefits can be described.
Studied preparation
The saved findings recognize the counted preparations; that does not resolve the supplied context's composition, population or outcome limitations.
Formulation logic100
No required partner is missing and no assessed conflict is recorded among the counted ingredients.
Partner coverage
The counted ingredients do not require an additional missing partner; no extra combination benefit is established.
Conflicts
No assessed conflict is recorded; this does not establish comprehensive interaction testing.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not proof of a clinically effective cosmetic dose.
Impact
High effect
Omega-3 · 1200 mg
Omega-3 fatty acids, including EPA and DHA, may provide small improvements in joint pain, stiffness or function in some inflammatory-joint and osteoarthritis settings. Findings are mixed, with important large trials showing no benefit. The evidence concerns sustained study regimens, so a label serving does not establish the same exposure or outcome, and it does not show cartilage repair or prevention.
How this product is rated for Joint Health
Ingredient fit74
Omega-3, EPA and DHA supply focused joint-related contributions.
Goal fit
Omega-3, EPA and DHA supply focused joint-related contributions.
Dose adequacy
The known fatty-acid amounts provide partial contributions.
Pathways20
Inflammation control receives the strongest saved coverage. Inflammation control has limited coverage below the saved breadth criterion.
Depth
Inflammation control receives the strongest saved coverage; this does not establish structural repair.
Breadth
Inflammation control has limited coverage below the saved breadth criterion.
Evidence69
Omega-3 anchors the saved evidence finding, with population, regimen and preparation limits on expected symptom benefit.
Evidence strength
Omega-3 anchors the saved evidence finding; the supplied clinical limitations remain relevant.
Studied preparation
The counted preparations are accepted in the saved finding; this does not establish identical clinical effects across products.
Formulation logic100
The counted ingredients work independently or have their required partner; no configured conflict was found.
Partner coverage
The counted ingredients work independently or have their required partner; no extra combination benefit is established.
Conflicts
No configured ingredient conflict was found.
Effective doses
All 3 counted ingredients provide meaningful amounts under the saved criteria.
Impact
Moderate effect
Omega-3 · 1200 mg
Whether omega-3 raises your resting calorie use is unclear for adults in general. Possible effects have varied between different groups of people, so they don't translate into a dependable metabolism boost from this serving. Changes in insulin-related processes are also different from an increase in whole-body energy expenditure.
How this product is rated for Metabolism Support
Ingredient fit51
Omega-3 has an uncertain effect on resting energy use across adults.
Goal fit
Omega-3 has an uncertain effect on resting energy use across adults.
Dose adequacy
The serving provides Omega-3 1200 mg. These amounts alone don't predict an increase in calorie burning.
Pathways42
The relevant connection is stimulation of energy use, with the size and persistence of any effect uncertain.
Depth
The relevant connection is stimulation of energy use, with the size and persistence of any effect uncertain.
Breadth
The connection is limited to stimulation of energy use, rather than several distinct effects on calorie burning.
Evidence89
Omega-3 has an uncertain effect on resting energy use across adults.
Evidence strength
Omega-3 has an uncertain effect on resting energy use across adults.
Studied preparation
The declared ingredient forms match the relevant preparation descriptions; this alone does not predict the size of a benefit.
Formulation logic100
No particular ingredient conflict or missing required partner is identified.
Partner coverage
No required companion ingredient is missing for the ingredient roles described here.
Conflicts
No particular ingredient conflict is identified.
Effective doses
Declared amounts allow comparison, but a dose reference is not a minimum effective amount for increasing calorie burning.
Impact
High effect
DHA contributes to brain membrane structure, while EPA and DHA have been studied with repeated omega-3 intake. The supplied evidence does not establish an immediate improvement in concentration from this serving. Positive DHA findings involved people with low intake taking it for months, and broader long-term omega-3 findings were not consistently positive. These distinctions limit what can be expected for acute mental focus.
How this product is rated for Mental Focus
Ingredient fit70
The serving has focus-related ingredients, with amount suitability and broader-purpose ingredients assessed separately.
Goal fit
The formula includes ingredients for other purposes, so its focus-related contribution is less concentrated.
Dose adequacy
The declared serving receives partial amount credit; matching an amount reference does not establish an effective dose for acute focus.
Pathways58
The saved mechanism finding is concentrated in the roles described below. Mechanism coverage does not establish clinical improvement.
Depth
The strongest mapped role is synaptic plasticity and neuroprotection; this describes the saved mechanism finding rather than a demonstrated clinical effect.
Breadth
Only one assessed route reaches the saved coverage threshold, so the mapped contribution remains narrow.
Evidence56
The strongest saved evidence finding and preparation matches are described separately. Scientific limitations still determine which focus benefits can be claimed.
Evidence strength
EPA leads the saved evidence finding, although omega-3 evidence does not establish acute concentration improvement.
Studied preparation
DHA (Docosahexaenoic Acid) does not match the saved studied-preparation requirement; the other qualifying ingredients do. This limits transfer of preparation-specific findings.
Formulation logic100
Partner requirements, recorded conflicts and minimum amounts shape the saved formulation finding.
Partner coverage
The saved partner check finds no missing required partner among the credited ingredients.
Conflicts
No configured conflict was recorded in the supplied facts; this is not a general safety assessment.
Effective doses
All credited ingredients meet the saved minimum amount threshold; that threshold does not prove a clinically effective focus dose.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Total Fat | 2 Gram(s) | |
Fish Oil concentrate | 2000 mg | |
Omega-3 Fatty Acids | 1200 mg | |
Eicosapentaenoic Acid | 800 mg | |
Docosahexaenoic Acid | 400 mg |
EPA (Eicosapentaenoic Acid) · 800 mg OverallScore76
Omega-3 · 1200 mg OverallScore66
Fish Oil · 2000 mg OverallScore69
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
- Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
- Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
- Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
- A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.